Patients with Mild Cognitive Impairment stratified by baseline blood plasma pTau217 show differences in CANTAB-assessed cognitive decline  

Stang NK, Kaula A, Taptiklis N, Cormack F et al. 

Presented at the Alzheimer’s Association International Conference (AAIC)
12-15 July 2026 | London, UK

Supplementary Material:  

Patients with Mild Cognitive Impairment stratified by baseline blood plasma pTau217 show differences in CANTAB-assessed cognitive decline

Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol

Haraldsen IH et al. Front Neurorobot. 2024;17:1289406.